CD28-B7 T Cell Costimulatory Blockade by CTLA4Ig in Sensitized Rat Recipients: Induction of Transplantation Tolerance in Association with Depressed Cell-Mediated and Humoral Immune Responses

Journal of Immunology

Volumn 159, Issue 4, 1997, Pages 1711-1717

  Onodera, Kazuhiko ^a   Chandraker, Anil ^b   Schaub, Meike ^b   Stadlbauer, Thomas H W ^a   Korom, Stephan ^a   Peach, Robert ^c   Linsley, Peter S ^c   Sayegh, Mohamed H ^b   Kupiec Weglinski, Jerzy W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BROWN NORWAY RAT; CELLULAR IMMUNITY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LEWIS RAT; MALE; MOUSE; PHYSIOLOGY; RAT;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNOCONJUGATES; MALE; MICE; RATS; RATS, INBRED BN; RATS, INBRED LEW;

EID: 0031571215     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sanfilippo, F. P., W. K. Vaughn, T. G. Peters, C. F. Shield, P. L. Adams, M. I. Lorber, and G. M. Williams. 1992. Factors affecting the waiting time of cadaveric kidney transplant candidates in the United States. JAMA 267:247.
2. Kupiec-Weglinski, J. W., and W. W. Hancock. 1996. Hyperacute and accelerated allograft rejection. In Transplantation Biology: Cellular and Molecular Aspects. N. L. Tilney, T. B. Strom, and L. C. Paul, eds. Lippincott-Raven Publishers, Philadelphia, p. 541.
3. + cells in the sensitization and effector phases of accelerated graft rejection. Transplantation 51:226.
4. Hancock, W. W., R. Di Stefano, P. Braun, R. Schweizer, N. L. Tilney, and J. W. Kupiec-Weglinski. 1990. CsA and anti-interleukin 2-receptor monoclonal antibody therapy in rats suppress accelerated rejection of cardiac allogratts through different effector mechanisms. Transplantation 48:416.
5. Kupiec-Weglinski, J. W., T. Sablinski, W. W. Hancock, R. Di Stefano, G. Mariani, C. T. Mix, and N. L. Tilney. 1991. Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy. Transplantation 51:300.
6. Onodera, K., M. Lehmann, E. Akalin, H. D. Volk, M. H. Sayegh, and J. W. Kupiec-Weglinski. 1996. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 mAb-treated sensitized rat recipients. J. Immunol. 157:1944.
7. Heidecke, C. D., W. W. Hancock, S. Westerholt, T. Sewczik, F. Jakobs, N. Zantl, A. Varzaru, A. Siegling, R. Kurrle, K. Deusch, H. D. Volk, and J. W. Kupiec-Weglinski. 1996. α/β-T cell receptor-directed therapy in rat allograft recipients: long-term survival of cardiac allografts after pretreatment with R73 mAb is associated with upregulation of Th2-type cytokines. Transplantation 61:948.
8. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
9. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
10. Thompson, C. B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 81:979.
11. Turka, I., A., P. S. Linsley, H. Lin, W. Brady, J. M. Leiden, R. Q. Wei, M. L. Gibson, X. G. Zheng, S. Myrdal, D. Gordon, T. Bailey, S. F. Bolling, and C. B. Thompson. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 89:11102.
12. Lin, H., S. F. Bolling, P. S. Linsley, R. Q. Wei, D. Gordon, C. B. Thompson, and L. A. Turka. 1993. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J. Exp. Med. 178:1801.
13. Pearson, T. C., D. Z. Alexander, K. J. Winn, P. S. Linsley, R. P. Lowry, and C. P. Larsen. 1994. Transplantation tolerance induced by CTLA4Ig. Transplantation 57:1701.
14. Sayegh, M. H., E. Akalin, W. W. Hancock, M. E. Russell, C. B. Carpenter, and L. A. Turka. 1995. CD2K-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181:1869.
15. Akalin, E., A. Chandraker, M. E. Russell, L. A. Turka, W. W. Hancock, and M. H. Sayegh. 1996. CU2S-B7 T cell costimulatory blockade by CTLA4Ig in the ral renal allograft model: inhibition of cell mediated and humoral immune responses in vivo. Transplantation 62:1942.
16. Russell, M. E., W. W. Hancock, E., Akalin, A. F. Wallace, T. Glysing-Jensen, T. Willett, and M. H. Sayegh. 1996. Chronic cardiac rejection in the Lewis to F344 rat model: blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J. Clin. Invest. 97:833.
17. Azuma, H., A. Chandraker, K. Nadeau, W. W. Hancock, C. B. Carpenter, N. L. Tilney, and M. H. Sayegh. 1996. Blockade of T cell costimulation prevents development of experimental chronic allograft rejection. Proc. Natl. Acad. Sci. USA 93:12439.
18. Linsley, P. S. P. M. Wallace, J. Johnson, M. G. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M. A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792.
19. Wallace, P. M., J. N. Rodgers, G. M. Leytze, J. S. Johnson, and P. S. Linsley. 1995. Induction and reversal of long-lived specific unresponsiveness to a T-dependent antigen following CTLA4Ig treatment. J. Immunol. 154:5885.
20. Pearson, T. C., D. Z. Alexander, R. Hendrix, E. T. Elwood, P. S. Linsley, K. J. Winn, and C. P. Larsen. 1996. CTLA4Ig plus bone marrow induces long-term allograft survival and donor-specific unresponsiveness in the murine model: evidence for hematopoietic chimerism. Transplantation 61:997.
21. Wallace, P. M., J. S. Johnson, J. F. MacMaster, K. A. Kennedy, P. Gladstone, and P. S. Linsley. 1994. CTLA4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers. Transplantation 58:602.
22. Hancock, W. W., M. H. Sayegh, X. G. Zheng, R. Peach, P. S. Linsley, and L. A. Turka. 1996. Costimulalory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. Sci. USA 93:13967.
23. Khoury, S. J., L. Gallon, R. R. Verburg, A. Chandraker, R. Peach, P. S. Linsley, L. A. Turka, W. W. Hancock, and M. H. Sayegh. 1996. Ex vivo treatment of antigen-presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat. J. Immunol. 157:3700.
24. Perico, N., Amuchestegyi, S., Bontempelli, M., and G. Remuzzi. 1996. CTLA4Ig alone or in combination with low-dose cyclosporine fails to reverse acute rejection of renal allografts in the rat. Transplantation 61:1320.
25. Kupiec-Weglinski, J. W., and N. L. Tilney. 1989. Lymphocyte migration patterns in organ allograft recipients. Immunol. Rev. 108:63.
26. Binder, J., M. H. Sayegh, B. Watschinger, W. W. Hancock, and J. W. Kupiec-Weglinski. 1994. Intrathymic injection of donor-specific x-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats. Transplantation 58:80.
27. Kawai, K., A., Shahinian, T. W. Mak, and P. S. Ohashi. 1996. Skin allograft rejection in CD28-delicient mice. Transplantation 61:352.
28. Pearson, T. C., D. Z. Alexander, R. Hendrix, E. T. Elwood, P. S. Linsley, K. J. Winn, and C. P. Larsen. 1996. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor-specific unresponsiveness in the murine model: evidence for hematopoietic chimerism Transplantation 61:997.
29. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA4. J. Immunol. 155:1032.
30. Judge, T. E., A. Tang, L. M. Spain, J. Gratiot-Deans, M. H. Sayegh, and L. A. Turka. 1996. The in vivo mechanisms of action of CTLA4Ig. J. Immunol. 156:2294.